Glycoscientific, L.L.C.

Athens, GA Doing business as Glycoscientific LLC

UEI
EUVNNWGFCA87
CAGE
5CAT5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
Center for Applied Genetic TECHNOLOGIES, 111 Riverbend Rd rm 261, Athens, GA 30602, USA
Website
glycoscientific.com
Founded
2009
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About Glycoscientific, L.L.C.

Glycoscientific, L.L.C., doing business as Glycoscientific LLC, is a research company and producer of standard reagents for glycan analysis and other glycobiology research. The company is developing tools to enable research in glycobiology, which focuses on the identification, characterization, and quantification of glycans and glycoconjugates.

Glycoscientific has been awarded federal contracts from the Department of Health and Human Services' National Institutes of Health and National Institute of Allergy and Infectious Diseases to provide reagents for immunologic analysis of non-mammalian and underrepresented mammalian models, as well as to enable the study of Mycobacterium tuberculosis infections in guinea pigs. These contracts were set aside for total small businesses and had potential values ranging from $600,000 to $653,191.

Glycoscientific has also received federal grants from NIH entities including the National Heart Lung and Blood Institute and the National Institute of General Medical Sciences. These grants funded the development of site-specific antibodies to recognize peptide sequences modified by O-GlcNAc glycosylation in order to study pulmonary arterial hypertension, as well as the production of isotopically labeled heparan sulfate glycosaminoglycan disaccharides for use as internal standards. The grants ranged in value from $252,114 to $298,483.

Quick answers

What is Glycoscientific, L.L.C.'s UEI?

Glycoscientific, L.L.C.'s Unique Entity ID (UEI) in SAM.gov is EUVNNWGFCA87.

What is Glycoscientific, L.L.C.'s CAGE code?

Glycoscientific, L.L.C.'s CAGE code is 5CAT5.

What is Glycoscientific, L.L.C.'s primary NAICS code?

Glycoscientific, L.L.C.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Glycoscientific, L.L.C. located?

Glycoscientific, L.L.C.'s physical address in SAM.gov is Center for Applied Genetic TECHNOLOGIES, 111 Riverbend Rd rm 261, Athens, GA 30602, USA.

Is Glycoscientific, L.L.C. registered in SAM.gov?

Yes. Glycoscientific, L.L.C.'s SAM.gov registration is active through August 25, 2027.

What is Glycoscientific, L.L.C.'s most recent federal award?

Glycoscientific, L.L.C.'s most recent federal contract award is Sbir topic 118: reagents for immunologic analysis of non-mammalian and underrepresented mammalian models (75N93023C00038), from National Institute of Allergy and Infectious Diseases, on September 1, 2023.

On GovTribe

See Glycoscientific, L.L.C.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors